Efficacy of injectable platelet rich fibrin in tempromandibular joint disorders.
- Conditions
- Temporomandibular joint disorders,
- Registration Number
- CTRI/2022/09/045320
- Lead Sponsor
- Aishla Jain
- Brief Summary
The study design is prospective, parallel arm randomized controlled trial to evaluate and compare the effectiveness of iPRF for relief of signs and symptoms in specific subgroups of temporomandibular disorders. The objectives of the study are to assess and compare the effect of iPRF on temperomandibular disorders in term of pain , tenderness, clicking and limited range of motion. The primary outcome measure will be assessment of pain through visual analogue scale and secondary outcome measures will be assessment of range of mandibular motion, tenderness of masticatory muscles – by manual palpation and clicking sound.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Patients with internal derangement of TMJ disorders classified under Wilkes stage II, III, IV and V.
- Autoimmune diseases 1.Benign or malignant temporomandibular joint lesions 2.Neurological disorders, 3.
- Blood diseases and coagulation disorders 4.
- Allergies or anaphylactic shock.
- History of peptic ulcers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of pain—VISUAL ANALOGUE SCALE. 0 day , 14 days 30 days , 60 days , 90 days
- Secondary Outcome Measures
Name Time Method 1) The range of mandibular motion (maximum unassisted opening (MUO), maximum assisted opening (MAO), protrusive movement (PM), right lateral excursion (RLE) and left
Trial Locations
- Locations (1)
PGIMER
🇮🇳Chandigarh, CHANDIGARH, India
PGIMER🇮🇳Chandigarh, CHANDIGARH, IndiaVIDYA RATTANPrincipal investigator9914900871drvidyarattan@gmail.com